| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.73B | +60.2% |
| Cost of Revenue | $2.22B | +59.6% |
| Gross Profit | $511.0M | +62.7% |
| R&D Expense | $282.0M | +73.0% |
| SG&A Expense | $294.0M | +55.6% |
| Operating Income | -$384.0M | -68.4% |
| Pre-tax Income | -$277.0M | +43.5% |
| Income Tax | -$2.0M | +33.3% |
| Net Income | -$275.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $547.0M | -32.4% |
| Accounts Receivable | $77.0M | +40.0% |
| Inventory | $110.0M | +161.9% |
| Current Assets | $1.41B | -5.3% |
| Total Assets | $1.76B | +1.5% |
| Current Liabilities | $496.0M | +40.9% |
| Total Liabilities | $663.0M | +3.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$156.0M | -7900.0% |
| Capital Expenditures | $16.0M | +33.3% |
| Investing Cash Flow | -$98.0M | +80.5% |
| Financing Cash Flow | $38.0M | -95.0% |
| Free Cash Flow | -$172.0M | -1620.0% |
| +43.5% |
| EPS (Basic) | -$0.54 | +67.9% |
| EPS (Diluted) | -$0.72 | +57.1% |
| Stockholders' Equity |
| $1.10B |
| +0.6% |